ADA and Cowden disease: There are increased remission rates in patients with moderate to severe CD in relation to serum ADA concentration, as shown by the study of Wyneski et al. [61]. In the study conducted by Fumery et al., results concluded that ADA is safe and effective in two-thirds of patients with pediatric-onset CD and IFX failure [62].